Release of Cyclooxygenase-2 and Lipoxin A from Blood Leukocytes in Aspirin-exacerbated Respiratory Disease
Background The release of cyclooxygenase-2 (COX-2) and lipoxin A 4 (LXA 4 ) from blood mononuclear cells in patients with aspirin-exacerbated respiratory disease (AERD) is only partially understood. Objective To investigate the presence of COX-2 and LXA 4 in peripheral blood mononuclear cells (PBMC)...
Main Authors: | Ajnacska Rozsasi M.D., Akos Heinemann M.D., Tilman Keck M.D. |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2016-09-01
|
Series: | Allergy & Rhinology |
Online Access: | https://doi.org/10.2500/ar.2016.7.0172 |
Similar Items
-
Mechanisms in anti-inflammation and resolution: the role of lipoxins and aspirin-triggered lipoxins
by: Fierro I.M., et al.
Published: (2001-01-01) -
Lipoxins and aspirin-triggered lipoxin alleviate bone cancer pain in association with suppressing expression of spinal proinflammatory cytokines
by: Hu Shan, et al.
Published: (2012-12-01) -
One- versus 2-day aspirin desensitization in aspirin exacerbated respiratory disease: A quality improvement project
by: Emily Gansert, BS, et al.
Published: (2023-11-01) -
Hereditary Hemorrhagic Telangiectasia and Aspirin-Exacerbated Respiratory Disease: A Case Report
by: James Reed Gardner MD, et al.
Published: (2021-03-01) -
Aspirin-exacerbated respiratory disease is associated with variants in filaggrin, epithelial integrity, and cellular interactions
by: Elina Jerschow, MD, MSc, et al.
Published: (2024-05-01)